|1.||Woods, Gail L: 12 articles (06/2004 - 04/2002)|
|2.||Nau, Roland: 9 articles (01/2015 - 07/2002)|
|3.||Unemo, Magnus: 8 articles (06/2014 - 07/2011)|
|4.||Gerber, Joachim: 7 articles (09/2005 - 07/2002)|
|5.||Hsueh, Po-Ren: 6 articles (12/2015 - 01/2002)|
|6.||van der Poll, Tom: 6 articles (04/2015 - 07/2003)|
|7.||File, Thomas M: 6 articles (02/2015 - 11/2002)|
|8.||Leib, Stephen L: 6 articles (01/2015 - 07/2006)|
|9.||Nicolau, David P: 6 articles (12/2014 - 12/2006)|
|10.||Friedland, H David: 6 articles (02/2014 - 12/2010)|
06/01/1988 - "As in earlier studies, which primarily used a twice-daily dosage regimen, few significant differences were found between therapeutic groups in comparative studies and results have demonstrated the efficacy of once-daily ceftriaxone in all but the most serious infections, such as sole antibiotic therapy in pseudomonal infections. "
04/15/1988 - "Our clinical studies demonstrated that an infection prophylaxis in gynaecological obstetrical standard operations is very effective with a single application of 1 g Ceftriaxone. "
08/01/1997 - "Treatment with ceftriaxone resulted in a marked improvement of neuropathic symptoms, providing indirect evidence of spirochetal infection. "
06/01/1984 - "If more widespread use confirms the safety and efficacy of ceftriaxone, it will offer an important alternative, particularly for the treatment of serious infections due to multidrug-resistant Gram-negative bacteria and in situations where the long half-life of the drug could result in worthwhile convenience and cost benefits."
07/01/2013 - "The recent identification of a high-level-ceftriaxone-resistant (MIC = 2 to 4 μg/ml) isolate of Neisseria gonorrhoeae from Japan (H041) portends the loss of ceftriaxone as an effective treatment for gonococcal infections. "
09/01/1991 - "One gram once daily of ceftriaxone is as effective as 2 gm for the common causative organisms of community-acquired and nosocomial pneumonias. "
07/01/1994 - "The effect of cytostatic treatment on the cellular defence and the efficacy of treatment with ceftriaxone in Klebsiella pneumoniae pneumonia was studied. "
10/01/2015 - "Ceftriaxone was the most common antibiotic associated with a recommendation (154/350, 44.0%); community-acquired pneumonia was the most common diagnosis (105/350, 30.0%). "
02/01/2015 - "Ceftriaxone with or without a macrolide antibiotic is a recommended treatment for patients with community-acquired pneumonia requiring hospital admission and intravenous antibiotic treatment. "
12/01/2014 - "To explore the perceptions of ED doctors regarding the use of ceftriaxone in patients with community-acquired pneumonia (CAP). "
08/09/1985 - "Several controlled comparative studies indicate that ceftriaxone is as effective as conventional treatment in therapy for neonatal or childhood meningitis caused by Streptococcus agalactiae, Escherichia coli, or H. "
08/15/2014 - "We previously have established a mouse model of neurobehavioural deficits, using an automated IntelliCage™ system that revealed long-term behavioural and cognitive deficits in C57BL/6J female mice cured of meningitis by ceftriaxone treatment. "
05/01/1995 - "A combination of ceftriaxone and ABPC, both of which were sensitive to the pathogen, were intravenously administered for one month, by which he responded well as to the meningitis. "
02/01/1984 - "Ceftriaxone, as a single agent, was comparable in efficacy with traditional antimicrobial therapy usually employed in childhood meningitis."
01/01/1983 - "The efficacy of ceftriaxone against group B streptococci was studied in vitro and in vivo with an infant rat model of group B streptococci bacteraemia and meningitis. "
08/01/1995 - "Our data suggest that most prepubertal children with gonorrhea are symptomatic at initial presentation and are cured after recommended treatment with ceftriaxone. "
10/01/2014 - "If oral treatment were 75% effective against decreased susceptibility gonorrhea, exclusive ceftriaxone use would likely increase cure rates in persons with decreased susceptibility gonorrhea, but could diminish them in persons with gonorrhea overall. "
12/01/2012 - "The new superbug Neisseria gonorrhoeae has retained resistance to antimicrobials previously recommended for first-line treatment and has now demonstrated its capacity to develop resistance to the extended-spectrum cephalosporin, ceftriaxone, the last remaining option for first-line empiric treatment of gonorrhea. "
01/01/2015 - "Currently Ceftriaxone is the last remaining antibiotic for first-line treatment of gonorrhea. "
07/01/1989 - "The Centers for Disease Control now recommends ceftriaxone for the first line treatment of gonorrhea but there are no data as to its use in children for this indication. "
|5.||Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
04/15/2014 - "IL-18(+/+) mice cured of pneumococcal meningitis with four doses of ceftriaxone, initiated at 20 h post-inoculation, showed enduring sequelae. "
01/01/2011 - "A 60-year-old man presented with pneumococcal meningitis which did not respond to the ceftriaxone therapy, in spite of in-vitro susceptibility (minimal inhibitory concentration of 0.016 μg/dLit) of the isolated organism to this antibacterial agent, although ceftriaxone is still the drug of choice for such pneumococcal meningitis. "
01/01/2011 - "First Report of a Case of Pneumococcal Meningitis Which Did Not Respond to the Ceftriaxone Therapy despite the Isolated Organism Being Sensitive to This Antibiotic In Vitro."
11/01/2005 - "We present a case of seven year old, human immune-deficiency virus positive girl, who developed gross swelling of the tongue and neck while on treatment for pneumococcal meningitis with ceftriaxone. "
12/22/2000 - "For this reason, spatial memory and learning was studied in a mouse model of ceftriaxone-treated Streptococcus pneumoniae meningitis. "
|8.||Anti-Bacterial Agents (Antibiotics)
|1.||Drug Therapy (Chemotherapy)